Injection Site Reactions in the Federal Adverse Event Reporting System (FAERS) Post-Marketing Database Vary Among Biologics Approved to Treat Moderate-To-Severe Psoriasis

• Main Authors: Elsie Grace (Author), Orin Goldblum (Author), Lisa Renda (Author), Noah Agada (Author), Kyoungah See (Author), Craig Leonardi (Author), Alan Menter (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2019-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction Biologics used to treat moderate-to-severe plaque psoriasis may cause injection site reactions (ISRs) characterized by erythema, edema, itch, and sometimes pain. The Federal Adverse Event Reporting System (FAERS) is a repository of spontaneous post-marketing reports of adverse...